| Sagent Pharmaceuticals Reports Fourth Quarter and Full-Year 2011 Financial Results - MarketWatch (press release) |
|
|
MarketWatch (press release) -- Revenue increased 44% to $48.5 million driven by product launches; -- Reported gross profit of $4.5 million, inclusive of $4.0 million in excess inventory reserves primarily related to a heparin code to service the dialysis market, which we are |